Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Preferences of German melanoma patients for interferon (IFN) α-2b toxicities (the DeCOG "GERMELATOX survey") versus melanoma recurrence to quantify patients' relative values for adjuvant therapy.

Kaehler KC, Blome C, Forschner A, Gutzmer R, Haalck T, Heinzerling L, Kornek T, Livingstone E, Loquai C, Maul LV, Lang BM, Schadendorf D, Stade B, Terheyden P, Utikal J, Wagner T, Hauschild A, Garbe C, Augustin M.

Medicine (Baltimore). 2016 Nov;95(46):e5375.

2.

New technologies for DNA analysis--a review of the READNA Project.

McGinn S, Bauer D, Brefort T, Dong L, El-Sagheer A, Elsharawy A, Evans G, Falk-Sörqvist E, Forster M, Fredriksson S, Freeman P, Freitag C, Fritzsche J, Gibson S, Gullberg M, Gut M, Heath S, Heath-Brun I, Heron AJ, Hohlbein J, Ke R, Lancaster O, Le Reste L, Maglia G, Marie R, Mauger F, Mertes F, Mignardi M, Moens L, Oostmeijer J, Out R, Pedersen JN, Persson F, Picaud V, Rotem D, Schracke N, Sengenes J, Stähler PF, Stade B, Stoddart D, Teng X, Veal CD, Zahra N, Bayley H, Beier M, Brown T, Dekker C, Ekström B, Flyvbjerg H, Franke A, Guenther S, Kapanidis AN, Kaye J, Kristensen A, Lehrach H, Mangion J, Sauer S, Schyns E, Tost J, van Helvoort JM, van der Zaag PJ, Tegenfeldt JO, Brookes AJ, Mir K, Nilsson M, Willcocks JP, Gut IG.

N Biotechnol. 2016 May 25;33(3):311-30. doi: 10.1016/j.nbt.2015.10.003. Epub 2015 Oct 26. Review.

PMID:
26514324
3.

Genomics and drug profiling of fatal TCF3-HLF-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options.

Fischer U, Forster M, Rinaldi A, Risch T, Sungalee S, Warnatz HJ, Bornhauser B, Gombert M, Kratsch C, Stütz AM, Sultan M, Tchinda J, Worth CL, Amstislavskiy V, Badarinarayan N, Baruchel A, Bartram T, Basso G, Canpolat C, Cario G, Cavé H, Dakaj D, Delorenzi M, Dobay MP, Eckert C, Ellinghaus E, Eugster S, Frismantas V, Ginzel S, Haas OA, Heidenreich O, Hemmrich-Stanisak G, Hezaveh K, Höll JI, Hornhardt S, Husemann P, Kachroo P, Kratz CP, Te Kronnie G, Marovca B, Niggli F, McHardy AC, Moorman AV, Panzer-Grümayer R, Petersen BS, Raeder B, Ralser M, Rosenstiel P, Schäfer D, Schrappe M, Schreiber S, Schütte M, Stade B, Thiele R, von der Weid N, Vora A, Zaliova M, Zhang L, Zichner T, Zimmermann M, Lehrach H, Borkhardt A, Bourquin JP, Franke A, Korbel JO, Stanulla M, Yaspo ML.

Nat Genet. 2015 Sep;47(9):1020-1029. doi: 10.1038/ng.3362. Epub 2015 Jul 27.

4.

Vaginal chlorhexidine during labour to prevent early-onset neonatal group B streptococcal infection.

Ohlsson A, Shah VS, Stade BC.

Cochrane Database Syst Rev. 2014 Dec 14;(12):CD003520. doi: 10.1002/14651858.CD003520.pub3. Review.

PMID:
25504106
5.

Early-onset Crohn's disease and autoimmunity associated with a variant in CTLA-4.

Zeissig S, Petersen BS, Tomczak M, Melum E, Huc-Claustre E, Dougan SK, Laerdahl JK, Stade B, Forster M, Schreiber S, Weir D, Leichtner AM, Franke A, Blumberg RS.

Gut. 2015 Dec;64(12):1889-97. doi: 10.1136/gutjnl-2014-308541. Epub 2014 Nov 3.

6.

GrabBlur--a framework to facilitate the secure exchange of whole-exome and -genome SNV data using VCF files.

Stade B, Seelow D, Thomsen I, Krawczak M, Franke A.

BMC Genomics. 2014;15 Suppl 4:S8. doi: 10.1186/1471-2164-15-S4-S8. Epub 2014 May 20.

7.

Whole genome and exome sequencing of monozygotic twins discordant for Crohn's disease.

Petersen BS, Spehlmann ME, Raedler A, Stade B, Thomsen I, Rabionet R, Rosenstiel P, Schreiber S, Franke A.

BMC Genomics. 2014 Jul 5;15:564. doi: 10.1186/1471-2164-15-564.

8.

Paleoproteomic study of the Iceman's brain tissue.

Maixner F, Overath T, Linke D, Janko M, Guerriero G, van den Berg BH, Stade B, Leidinger P, Backes C, Jaremek M, Kneissl B, Meder B, Franke A, Egarter-Vigl E, Meese E, Schwarz A, Tholey A, Zink A, Keller A.

Cell Mol Life Sci. 2013 Oct;70(19):3709-22. doi: 10.1007/s00018-013-1360-y. Epub 2013 Jun 6.

PMID:
23739949
9.

Association between variants of PRDM1 and NDP52 and Crohn's disease, based on exome sequencing and functional studies.

Ellinghaus D, Zhang H, Zeissig S, Lipinski S, Till A, Jiang T, Stade B, Bromberg Y, Ellinghaus E, Keller A, Rivas MA, Skieceviciene J, Doncheva NT, Liu X, Liu Q, Jiang F, Forster M, Mayr G, Albrecht M, Häsler R, Boehm BO, Goodall J, Berzuini CR, Lee J, Andersen V, Vogel U, Kupcinskas L, Kayser M, Krawczak M, Nikolaus S, Weersma RK, Ponsioen CY, Sans M, Wijmenga C, Strachan DP, McArdle WL, Vermeire S, Rutgeerts P, Sanderson JD, Mathew CG, Vatn MH, Wang J, Nöthen MM, Duerr RH, Büning C, Brand S, Glas J, Winkelmann J, Illig T, Latiano A, Annese V, Halfvarson J, D'Amato M, Daly MJ, Nothnagel M, Karlsen TH, Subramani S, Rosenstiel P, Schreiber S, Parkes M, Franke A.

Gastroenterology. 2013 Aug;145(2):339-47. doi: 10.1053/j.gastro.2013.04.040. Epub 2013 Apr 25.

10.

From next-generation sequencing alignments to accurate comparison and validation of single-nucleotide variants: the pibase software.

Forster M, Forster P, Elsharawy A, Hemmrich G, Kreck B, Wittig M, Thomsen I, Stade B, Barann M, Ellinghaus D, Petersen BS, May S, Melum E, Schilhabel MB, Keller A, Schreiber S, Rosenstiel P, Franke A.

Nucleic Acids Res. 2013 Jan 7;41(1):e16. doi: 10.1093/nar/gks836. Epub 2012 Sep 10.

11.

Improving mapping and SNP-calling performance in multiplexed targeted next-generation sequencing.

Elsharawy A, Forster M, Schracke N, Keller A, Thomsen I, Petersen BS, Stade B, Stähler P, Schreiber S, Rosenstiel P, Franke A.

BMC Genomics. 2012 Aug 22;13:417. doi: 10.1186/1471-2164-13-417.

12.

Folic acid transport to the human fetus is decreased in pregnancies with chronic alcohol exposure.

Hutson JR, Stade B, Lehotay DC, Collier CP, Kapur BM.

PLoS One. 2012;7(5):e38057. doi: 10.1371/journal.pone.0038057. Epub 2012 May 29.

13.

New insights into the Tyrolean Iceman's origin and phenotype as inferred by whole-genome sequencing.

Keller A, Graefen A, Ball M, Matzas M, Boisguerin V, Maixner F, Leidinger P, Backes C, Khairat R, Forster M, Stade B, Franke A, Mayer J, Spangler J, McLaughlin S, Shah M, Lee C, Harkins TT, Sartori A, Moreno-Estrada A, Henn B, Sikora M, Semino O, Chiaroni J, Rootsi S, Myres NM, Cabrera VM, Underhill PA, Bustamante CD, Vigl EE, Samadelli M, Cipollini G, Haas J, Katus H, O'Connor BD, Carlson MR, Meder B, Blin N, Meese E, Pusch CM, Zink A.

Nat Commun. 2012 Feb 28;3:698. doi: 10.1038/ncomms1701.

PMID:
22426219
14.

Transcutaneous bilirubin measurement at the time of hospital discharge in a multiethnic newborn population.

Campbell DM, Danayan KC, McGovern V, Cheema S, Stade B, Sgro M.

Paediatr Child Health. 2011 Mar;16(3):141-5.

15.

Feeling different: the experience of living with fetal alcohol spectrum disorder.

Stade B, Beyene J, Buller K, Ross S, Patterson K, Stevens B, Sgro M, Ungar W, Watson W, Koren G.

J Popul Ther Clin Pharmacol. 2011;18(3):e475-85. Epub 2011 Oct 3.

PMID:
22042791
16.

What do we know about the economic impact of fetal alcohol spectrum disorder? A systematic literature review.

Popova S, Stade B, Bekmuradov D, Lange S, Rehm J.

Alcohol Alcohol. 2011 Jul-Aug;46(4):490-7. doi: 10.1093/alcalc/agr029. Epub 2011 Apr 22. Review.

PMID:
21515625
17.

Evaluating the cost of fetal alcohol spectrum disorder.

Popova S, Stade B, Johnston M, MacKay H, Lange S, Bekmuradov D, Rehm J.

J Stud Alcohol Drugs. 2011 Jan;72(1):163-4. No abstract available.

PMID:
21138723
18.

The remarkably high prevalence of epilepsy and seizure history in fetal alcohol spectrum disorders.

Bell SH, Stade B, Reynolds JN, Rasmussen C, Andrew G, Hwang PA, Carlen PL.

Alcohol Clin Exp Res. 2010 Jun;34(6):1084-9. doi: 10.1111/j.1530-0277.2010.01184.x. Epub 2010 Apr 5.

PMID:
20374205
19.

Psychological and/or educational interventions for reducing alcohol consumption in pregnant women and women planning pregnancy.

Stade BC, Bailey C, Dzendoletas D, Sgro M, Dowswell T, Bennett D.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD004228. doi: 10.1002/14651858.CD004228.pub2. Review.

20.

Oculomotor control in children with fetal alcohol spectrum disorders assessed using a mobile eye-tracking laboratory.

Green CR, Mihic AM, Brien DC, Armstrong IT, Nikkel SM, Stade BC, Rasmussen C, Munoz DP, Reynolds JN.

Eur J Neurosci. 2009 Mar;29(6):1302-9. doi: 10.1111/j.1460-9568.2009.06668.x.

PMID:
19302166
21.

Executive function deficits in children with fetal alcohol spectrum disorders (FASD) measured using the Cambridge Neuropsychological Tests Automated Battery (CANTAB).

Green CR, Mihic AM, Nikkel SM, Stade BC, Rasmussen C, Munoz DP, Reynolds JN.

J Child Psychol Psychiatry. 2009 Jun;50(6):688-97. doi: 10.1111/j.1469-7610.2008.01990.x. Epub 2008 Oct 23.

PMID:
19175817
22.

The burden of prenatal exposure to alcohol: revised measurement of cost.

Stade B, Ali A, Bennett D, Campbell D, Johnston M, Lens C, Tran S, Koren G.

Can J Clin Pharmacol. 2009 Winter;16(1):e91-102. Epub 2009 Jan 23.

PMID:
19168935
23.

Cost of fetal alcohol spectrum disorder in Canada.

Stade B, Ungar WJ, Stevens B, Beyen J, Koren G.

Can Fam Physician. 2007 Aug;53(8):1303-4.

24.

Health-related quality of life of Canadian children and youth prenatally exposed to alcohol.

Stade BC, Stevens B, Ungar WJ, Beyene J, Koren G.

Health Qual Life Outcomes. 2006 Oct 13;4:81.

25.

Vaginal chlorhexidine during labour to prevent early-onset neonatal group B streptococcal infection.

Stade B, Shah V, Ohlsson A.

Cochrane Database Syst Rev. 2004;(3):CD003520. Review. Update in: Cochrane Database Syst Rev. 2014;12:CD003520.

PMID:
15266490
26.

Cultural differences and parental responses to the preterm infant at risk: strategies for supporting families.

Bracht M, Kandankery A, Nodwell S, Stade B.

Neonatal Netw. 2002 Sep-Oct;21(6):31-8. Review.

PMID:
12240512
27.

A semidemand feeding protocol reduced time to full oral feeding in healthy preterm infants.

Stade B, Bishop C.

Evid Based Nurs. 2002 Jul;5(3):74. No abstract available.

28.

Communication needs of patients receiving mechanical ventilation: a pilot study.

Fitch MI, Remus S, Stade B.

Off J Can Assoc Crit Care Nurs. 1998 Fall;9(3):16-23.

PMID:
10347491
29.

Autotransplantation of B-cell purged peripheral blood progenitor cells in B-cell lymphoma.

Straka C, Drexler E, Mitterer M, Langenmayer I, Pfefferkorn L, Stade B, Koll R, Emmerich B.

Lancet. 1995 Mar 25;345(8952):797-8. No abstract available.

PMID:
7891509
30.
31.

Metastasis formation in human solid tumors: phenotypic characteristics of early metastatic cells.

Riethmüller G, Schlimok G, Pantel K, Angstwurm M, Izbicki J, Karg O, Stade BG, Johnson JP.

Behring Inst Mitt. 1992 Apr;(91):204-9. Review. No abstract available.

PMID:
1355966
32.

Structural characteristics of the 5' region of the human ICAM-1 gene.

Stade BG, Messer G, Riethmüller G, Johnson JP.

Immunobiology. 1990 Dec;182(1):79-87.

PMID:
1983003
33.

De novo expression of intercellular-adhesion molecule 1 in melanoma correlates with increased risk of metastasis.

Johnson JP, Stade BG, Holzmann B, Schwäble W, Riethmüller G.

Proc Natl Acad Sci U S A. 1989 Jan;86(2):641-4.

34.

Functional aspects of three molecules associated with metastasis development in human malignant melanoma.

Johnson JP, Lehmann JM, Stade BG, Rothbächer U, Sers C, Riethmüller G.

Invasion Metastasis. 1989;9(6):338-50. Review.

PMID:
2574717
35.

The melanoma progression-associated antigen P3.58 is identical to the intercellular adhesion molecule, ICAM-1.

Johnson JP, Stade BG, Hupke U, Holzmann B, Riethmüller G.

Immunobiology. 1988 Dec;178(3):275-84.

PMID:
3229781

Supplemental Content

Support Center